Patient Voice in Real World Evidence (RWE): Advances, Opportunities & Actions
Welcome to this webinar where we will be discussing opportunities and challenges for incorporating the patient voice in RWE and how this evidence can improve decision-making.
Real-world evidence (RWE) is becoming increasingly valuable to regulators, health technology assessment agencies, and payers. As more attention is directed towards patient-centricity in drug development and evidence generation, there is a growing role of the patient voice in RWE. Advances in RWD capture, analytical methods, and RWE guidance from decision-makers are enabling patients to share and benefit from the growing RWE efforts.
Key insights include:
- RWE: An overview
- Value of RWE across the product lifecycle
- Growing role of patient voice in RWE
- Opportunities and challenges to using patient-centric RWE
- Call to action
- Life Sciences
- Real World Evidence
- Health economics & observational research (HEOR)
- Late Stage Development
- Clinical Development
- HTA Bodies
- Patient Advocacy Groups
Ashley Jaksa - MPH Scientific Partnerships Lead at Aetion
Ashley leads engagements with HTA and Regulatory bodies to assist in setting standards around RWE generation and use in decision-making. She works with biopharma customers to develop RWE that meets the needs of regulators and HTAs and has previously lead Analytical Services at Context Matters, where she consulted with biopharma on designing and executing HTA focused analysis. Previously, Ashley worked for CVS Health, a leading U.S. PBM & Specialty Pharmacy. She has a MPH from Yale University and a BA from the University of Michigan.
Chung Yen Looi, DPhil - Partnerships Director at Monsenso
Looi leads global partnerships with Life Sciences at Monsenso to enable real-world patient data capture from clinical, post-market to RWE studies. Previously, she partnered with global Payers, Providers, Research Organisations & Life Sciences at Oxford VR, digital therapeutics company and Cambridge Cognition, digital neuroscience company to improve access to evidence-based mental health treatments. Looi is a Chartered Psychologist who is registered with the British Psychological Society. She completed her DPhil in Experimental Psychology from Oxford.